News Conference News TCT 2024 Co-STAR Hints That Colchicine May Curb Rhythm Disturbances After TAVI Michael O'Riordan November 06, 2024
News Conference News TCT 2024 More Registry Data Show Post-TAVI Benefits With Sentinel but No Stroke Impact Yael L. Maxwell October 28, 2024
News Conference News EACTS 2024 TAVI Explant Complications a ‘Big Issue’ as Procedure Numbers Climb Yael L. Maxwell October 21, 2024
News Conference News HFSA 2024 EXPANDed: Atrial Secondary MR Patients Get Clinical Benefit From TEER Caitlin E. Cox October 03, 2024
News Conference News ESC 2024 Balloon-Expandable TAVI Superior to SAVR in Women at 1 Year: RHEIA Caitlin E. Cox September 04, 2024
News Daily News Similar Safety, Efficacy With Leadless vs Transvenous Pacemakers at 2 Years Post-TAVI Yael L. Maxwell July 26, 2024
News Daily News FDA Medical Devices Chief Jeff Shuren Announces Retirement L.A. McKeown July 24, 2024
News Daily News Evolut TAVI Shows Promise in Low-risk Bicuspid Patients at 3 Years Yael L. Maxwell July 22, 2024
News Daily News The Hole Story: Interatrial Shunt Companies Are—Mostly—Pushing Ahead Michael O'Riordan June 20, 2024
News Conference News NY Valves 2024 AV Block Common After Transcatheter Tricuspid Valve Replacement for TR Michael O'Riordan June 07, 2024
News Conference News NY Valves 2024 Risk Score IDs Patients Safe for Same-Day Discharge After Low-Risk TAVI Michael O'Riordan June 06, 2024
News Conference News EuroPCR 2024 Temporary Pacemaker After TAVI May Preclude Long-term Pacing Caitlin E. Cox May 24, 2024
News Conference News EuroPCR 2024 TAVI, Surgery Look Similar Long-term Across Risk Spectrum: Meta-analysis Michael O'Riordan May 16, 2024
News Conference News EuroPCR 2024 Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids Michael O'Riordan May 15, 2024
News Conference News EuroPCR 2024 Myval Matches Contemporary TAVI at 30 Days, but Do More Sizes Matter? Shelley Wood May 15, 2024
News Conference News TAVI Use Rising in Young US Patients, Yet Another Analysis Shows Yael L. Maxwell May 06, 2024
News Conference News ACC 2024 Another Win for TAVI in Patients at Low-to-Intermediate Risk: DEDICATE-DZHK6 Yael L. Maxwell April 08, 2024
News Daily News Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective Michael O'Riordan February 23, 2024